Fluconazole Oral Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 100 mg, 150 mg, 200 mg
Reference Brands: Diflucan(EU & US)
Category:
Anti-fungal
Fluconazole is an antifungal that inhibits fungal cell membrane synthesis by blocking the enzyme lanosterol 14α-demethylase. It effectively treats candidiasis,Cryptococcal meningitis, and other fungal infections. Benefits include oral administration, broad-spectrum activity, excellent tissue penetration, and a favorable safety profile, making it essential in managing systemic fungal infections.
Fluconazole Oral Tablets is available in Tablets
and strengths such as 50 mg, 100 mg, 150 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluconazole Oral Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluconazole Oral Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluconazole tablets are approved in the EU and US for treating fungal infections. In the EU, Pfizer’s Diflucan and generics are regulated by the EMA, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, the FDA approved Diflucan and generic versions based on detailed clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require robust dossiers for approval and post-marketing surveillance. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing